PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS

The National Institutes of Health, National Institute on Drug Abuse (NIDA), is soliciting proposals under solicitation number 75N95024R00003 for the preparation and distribution of research drug products. This initiative supports the NIDA Drug Supply Program by providing the research community with a variety of authentic controlled and uncontrolled drug compounds, specific dosage forms, and marijuana and nicotine research cigarettes. The requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.

The contractor will manage the acquisition, development, and preparation of drug dosage forms, including the capability to import compounds from international sources and manufacture research-grade materials. Responsibilities include the frequent purity analysis, storage, and distribution of substances such as morphine, methadone, naltrexone pellets, and various cannabinoid preparations. All activities must be conducted according to DEA regulations to aid NIDA in promoting drug abuse and addiction research. Work will be performed in the United States and managed through the issuance of task orders for the acquisition and shipment of bulk drugs and other chemical compounds.

The response deadline for this solicitation is November 15, 2024. The notice was originally published on October 1, 2024, and includes three attachments: the original solicitation and two subsequent amendments. Scott Duernberger is the designated point of contact for this federal opportunity.